Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00956631 · ClinicalTrials.gov registry record · Phase 4
MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study
A Phase 4 study, sponsored by Vertos Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 78
- Enrollment target
NCT00956631: Completed Phase 4 study, sponsored by Vertos Medical.
NCT00956631 is a Phase 4 study that has completed, run by Vertos Medical. The registered enrollment target is 78 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00956631, a Phase 4 study, has completed, sponsored by Vertos Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 78 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, clinical study to assess the clinical application and outcomes of MILD® Interlaminar Decompression in patients with symptomatic lumbar spinal stenosis.
Primary Outcome
The 10-point Visual Analog Scale rates 'no pain' as zero and 'worst pain imaginable' as ten. Visual analog scores of mean improvement greater than or equal to 2.0 are clinically relevant. The change from baseline to six months is reported below, where a positive value represents the baseline value minus the 6 month value.
Interventions
- PROCEDURE Interlaminar Decompression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
What the finished NCT00956631 record still lists
NCT00956631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Interlaminar Decompression is the first listed.
NCT00956631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00956631 about?
NCT00956631 is a clinical study titled "MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study". This is a multi-center, prospective, clinical study to assess the clinical application and outcomes of MILD® Interlaminar Decompression in patients with symptomatic lumbar spinal stenosis.
What is the current status of trial NCT00956631?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2008-07. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00956631?
The interventions under investigation include: Interlaminar Decompression (PROCEDURE).
Who is sponsoring clinical trial NCT00956631?
This trial is sponsored by Vertos Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00956631's enrollment target sits among peer trials
78 982nd of 2000 higher than 1,012 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia